Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ0700052	丙酸氟替卡松粉雾剂	fluticasone propionate	Powder for inhalation	Chemical Drugs	License Renew	2007-05-08	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations	Certificate Issued	2008-01-25	view
JYHZ0700224	头孢呋辛酯片	cefuroxime axetil	Tablet	Chemical Drugs	License Renew	2007-10-11	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations	Certificate Issued	2008-07-09	view
JYHB0900137	沙美特罗替卡松粉吸入剂	fluticasone propionate;salmeterol xinafoate	Inhalation	Chemical Drugs	Supplementary Application	2009-03-05	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations	Certificate Issued	2009-10-22	view
JYHB1401292	羟萘酸沙美特罗吸入粉雾剂	Salmeterol Hydroxynaphthoate	Powder for inhalation	Chemical Drugs	Supplementary Application	2014-09-22	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations	Certificate Issued	2015-10-30	view
JYHB1601017	丙酸倍氯米松鼻喷雾剂	beclometasone dipropionate	Spray	Chemical Drugs	Supplementary Application	2016-08-11	GLAXO WELLCOME UK LIMITED T/A ALLEN AND HANBURYS	Glaxo Wellcome Operations	Certificate Issued	2017-12-19	view